Toxicity profi le of lithium

The Lancet

Volumn 379, Issue 9834, 2012, Pages 2338-

  Wells, J Elisabeth ^a   Cross, Nick B ^b   Richardson, Ann K ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; HUMAN; INCIDENCE; KIDNEY FAILURE; LETTER; LONG TERM CARE; PREVALENCE; PRIORITY JOURNAL; MOOD DISORDER; NOTE;

ANTIPSYCHOTIC AGENTS; HUMANS; LITHIUM; MOOD DISORDERS;

EID: 84862627047     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61012-5     Document Type: Letter

References (4)

1. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012; 379: 721-28.
2. Bendz H, Schon S, Attman P-O, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 2010; 77: 219-24.
3. Presne C, Fakhouri F, Noel L-H, et al. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int 2003; 64: 585-92.
4. Australian Institute of Health and Welfare. End-stage kidney disease in Australia: total incidence 2003-2007. Canberra: AIHW, 2011.